| Year |
Citation |
Score |
| 2022 |
Taurin S, Rosengren RJ. Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines. Medical Oncology (Northwood, London, England). 40: 45. PMID 36494506 DOI: 10.1007/s12032-022-01909-3 |
0.327 |
|
| 2017 |
Greish K, Jasim A, Parayath N, Abdelghany S, Alkhateeb A, Taurin S, Nehoff H. Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme. Journal of Drug Targeting. 1-17. PMID 29251531 DOI: 10.1080/1061186X.2017.1419357 |
0.372 |
|
| 2017 |
Martey O, Nimick M, Taurin S, Sundararajan V, Greish K, Rosengren RJ. Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer. International Journal of Nanomedicine. 12: 7225-7237. PMID 29042771 DOI: 10.2147/Ijn.S148908 |
0.318 |
|
| 2017 |
Taurin S, Yang CH, Reyes M, Cho S, Coombs DM, Jarboe EA, Werner TL, Peterson CM, Janát-Amsbury MM. Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 28953502 DOI: 10.1097/Igc.0000000000001129 |
0.321 |
|
| 2017 |
Taurin S, Yang C, Reyes M, Cho S, Jarboe EA, Werner TL, Coombs DM, Chen P, Janát-Amsbury MM. Abstract 3244: Treatment of endometrial cancer cells with a new small tyrosine kinase inhibitor targeting mutated fibroblast growth factor receptor-2 Cancer Research. 77: 3244-3244. DOI: 10.1158/1538-7445.Am2017-3244 |
0.377 |
|
| 2016 |
Archibald M, Pritchard T, Nehoff H, Rosengren RJ, Greish K, Taurin S. A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer. International Journal of Nanomedicine. 11: 179-200. PMID 26811677 DOI: 10.2147/Ijn.S97286 |
0.37 |
|
| 2015 |
Taurin S, Nimick M, Larsen L, Rosengren RJ. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines. International Journal of Oncology. PMID 26648459 DOI: 10.3892/Ijo.2015.3252 |
0.393 |
|
| 2015 |
Nehoff H, Parayath NN, McConnell MJ, Taurin S, Greish K. A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme. Oncotarget. PMID 26517812 DOI: 10.18632/Oncotarget.5698 |
0.385 |
|
| 2015 |
Parayath NN, Nehoff H, Müller P, Taurin S, Greish K. Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery - dual uptake through enterocytes and M-cells. International Journal of Nanomedicine. 10: 4653-67. PMID 26229468 DOI: 10.2147/Ijn.S87681 |
0.305 |
|
| 2015 |
Nehoff H, Parayath N, Taurin S, Greish K. ATPS-58COMBINATION TYROSINE KINASE INHIBITORS EFFECTIVELY OVERCOME THE APOPTOSIS RESISTANCE, INVASIVE POTENTIAL AND ANGIOGENIC CAPACITY OF GLIOBLASTOMA MULTIFORME CELLS Neuro-Oncology. 17: v31.1-v31. DOI: 10.1093/Neuonc/Nov204.58 |
0.418 |
|
| 2013 |
Taurin S, Allen KM, Scandlyn MJ, Rosengren RJ. Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expression. International Journal of Oncology. 43: 785-92. PMID 23842642 DOI: 10.3892/Ijo.2013.2012 |
0.342 |
|
| 2012 |
Yadav B, Taurin S, Larsen L, Rosengren RJ. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models. International Journal of Oncology. 41: 1723-32. PMID 22971638 DOI: 10.3892/Ijo.2012.1625 |
0.404 |
|
| 2012 |
Yadav B, Taurin S, Larsen L, Rosengren RJ. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells. International Journal of Oncology. 41: 1119-27. PMID 22710975 DOI: 10.3892/Ijo.2012.1521 |
0.407 |
|
| 2012 |
Taurin S, Yadav BD, Nimick M, Rosengren RJ. Abstract 4669: A combination of raloxifene and gefitinib potentiates the cytotoxicity and induces apoptosis in estrogen receptor negative breast cancer cell lines Cancer Research. 72: 4669-4669. DOI: 10.1158/1538-7445.Am2012-4669 |
0.379 |
|
| 2011 |
Somers-Edgar TJ, Taurin S, Larsen L, Chandramouli A, Nelson MA, Rosengren RJ. Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines. Investigational New Drugs. 29: 87-97. PMID 19816657 DOI: 10.1007/S10637-009-9339-0 |
0.406 |
|
| 2010 |
Yadav B, Taurin S, Rosengren RJ, Schumacher M, Diederich M, Somers-Edgar TJ, Larsen L. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorganic & Medicinal Chemistry. 18: 6701-7. PMID 20728364 DOI: 10.1016/J.Bmc.2010.07.063 |
0.395 |
|
| 2010 |
Yadav BD, Taurin S, Larsen L, Rosengren RJ. Abstract 3556: New curcumin analogues are cytotoxic towards estrogen receptor negative human breast cancer cell lines Cancer Research. 70: 3556-3556. DOI: 10.1158/1538-7445.Am10-3556 |
0.369 |
|
| 2009 |
Sun Q, Taurin S, Sethakorn N, Long X, Imamura M, Wang DZ, Zimmer WE, Dulin NO, Miano JM. Myocardin-dependent activation of the CArG box-rich smooth muscle gamma-actin gene: preferential utilization of a single CArG element through functional association with the NKX3.1 homeodomain protein. The Journal of Biological Chemistry. 284: 32582-90. PMID 19797053 DOI: 10.1074/Jbc.M109.033910 |
0.323 |
|
| 2009 |
Taurin S, Sandbo N, Yau DM, Sethakorn N, Kach J, Dulin NO. Phosphorylation of myocardin by extracellular signal-regulated kinase. The Journal of Biological Chemistry. 284: 33789-94. PMID 19776005 DOI: 10.1074/Jbc.M109.048983 |
0.334 |
|
| 2008 |
Akimova OA, Taurin S, Dulin NO, Orlov SN. Purinergic inhibition of Na⁺,K⁺,Cl⁻ cotransport in C11-MDCK cells: Role of stress-activated protein kinases. Purinergic Signalling. 4: 183-91. PMID 18368525 DOI: 10.1007/S11302-007-9057-Z |
0.578 |
|
| 2008 |
Taurin S, Sandbo N, Yau DM, Sethakorn N, Dulin NO. Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. American Journal of Physiology. Cell Physiology. 294: C1169-74. PMID 18353896 DOI: 10.1152/Ajpcell.00096.2008 |
0.381 |
|
| 2007 |
Haloui M, Taurin S, Akimova OA, Guo DF, Tremblay J, Dulin NO, Hamet P, Orlov SN. [Na]i -induced c-Fos expression is not mediated by activation of the 5' -promoter containing known transcriptional elements. The Febs Journal. 274: 3557-67. PMID 17565602 DOI: 10.1111/J.1742-4658.2007.05885.X |
0.62 |
|
| 2007 |
Taurin S, Hogarth K, Sandbo N, Yau DM, Dulin NO. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3. The Journal of Biological Chemistry. 282: 19518-25. PMID 17513863 DOI: 10.1074/Jbc.M702655200 |
0.36 |
|
| 2007 |
Sandbo N, Taurin S, Yau DM, Kregel S, Mitchell R, Dulin NO. Downregulation of smooth muscle alpha-actin expression by bacterial lipopolysaccharide. Cardiovascular Research. 74: 262-9. PMID 17303098 DOI: 10.1016/J.Cardiores.2007.01.011 |
0.327 |
|
| 2006 |
Taurin S, Sandbo N, Qin Y, Dulin NO. 21 PHOSPHORYLATION OF b-CATENIN BY PROTEIN KINASE A IN VASCULAR SMOOTH MUSCLE CELLS. Journal of Investigative Medicine. 54: S347.1-S347. DOI: 10.2310/6650.2005.X0015.20 |
0.339 |
|
| 2005 |
Akimova AO, Bourcier N, Taurin S, Bundey RA, Grygorczyk K, Gekle M, Insel PA, Dulin NO, Orlov SN. Cl- secretion in ATP-treated renal epithelial C7-MDCK cells is mediated by activation of P 2Y1 receptors, phospholipase A2 and protein kinase A. The Journal of Physiology. 568: 789-801. PMID 16109726 DOI: 10.1113/Jphysiol.2005.094375 |
0.569 |
|
| 2005 |
Sandbo N, Qin Y, Taurin S, Hogarth DK, Kreutz B, Dulin NO. Regulation of serum response factor-dependent gene expression by proteasome inhibitors. Molecular Pharmacology. 67: 789-97. PMID 15550677 DOI: 10.1124/Mol.104.006874 |
0.369 |
|
| 2004 |
Hogarth DK, Sandbo N, Taurin S, Kolenko V, Miano JM, Dulin NO. Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP. American Journal of Physiology. Cell Physiology. 287: C449-56. PMID 15238360 DOI: 10.1152/Ajpcell.00547.2003 |
0.409 |
|
| 2004 |
Orlov SN, Thorin-Trescases N, Pchejetski D, Taurin S, Farhat N, Tremblay J, Thorin E, Hamet P. Na+/K+ pump and endothelial cell survival: [Na+]i/[K+]i-independent necrosis triggered by ouabain, and protection against apoptosis mediated by elevation of [Na+]i. PflüGers Archiv : European Journal of Physiology. 448: 335-45. PMID 15069561 DOI: 10.1007/S00424-004-1262-9 |
0.63 |
|
| 2004 |
Orlov SN, Pchejetski D, Taurin S, Thorin-Trescases N, Maximov GV, Pshezhetsky AV, Rubin AB, Hamet P. Apoptosis in serum-deprived vascular smooth muscle cells: evidence for cell volume-independent mechanism. Apoptosis : An International Journal On Programmed Cell Death. 9: 55-66. PMID 14739599 DOI: 10.1023/B:Appt.0000012122.47197.03 |
0.64 |
|
| 2004 |
Taurin S, Pchejetski D, Thorin-Trescase N, Tremblay J, Harriet P, Orlov SN. INTRACELLULAR SODIUM PROTECTS VASCULAR ENDOTHELIAL CELLS FROM APOPTOSIS TRIGGERED BY [3H]-DECAY-INDUCED DNA DAMAGE Journal of Hypertension. 22: S50-S51. DOI: 10.1097/00004872-200406002-00169 |
0.576 |
|
| 2004 |
Orlov SN, Pchejetski D, Thorin-Trescase N, Taurin S, Tremblay J, Harriet P. ENDOTHELIAL CELL DEATH TRIGGERED BY OUABAIN Journal of Hypertension. 22: S9-S10. DOI: 10.1097/00004872-200406002-00024 |
0.573 |
|
| 2004 |
Orlov SN, Pchejetski D, Taurin S, Tremblay J, Harriet P. APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS Journal of Hypertension. 22: S7. DOI: 10.1097/00004872-200406002-00014 |
0.575 |
|
| 2004 |
Orlov SN, Pchejetski D, Taurin S, Tremblay J, Hamet P. Apoptosis In Serum-Deprived Vascular Smooth Muscle Cells (Vsmc): Evidence For Cell Volume-Independent Mechanism Cardiovascular Pathology. 13: 166. DOI: 10.1016/J.Carpath.2004.03.501 |
0.589 |
|
| 2004 |
Hogarth DK, Sandbo N, Elinoff J, Taurin S, Dulin N. Dual Role Of Pka In The Phenotypic Modulation Of Vascular Smooth Muscle Cells By Extracellular Atp Cardiovascular Pathology. 13: 163. DOI: 10.1016/J.Carpath.2004.03.491 |
0.373 |
|
| 2004 |
Taurin S, Pchejetski D, Thorin-Trescases N, Tremblay J, Hamet P, Orlov SN. ELEVATION OF [NA+]I PROTECTS ENDOTHELIAL CELLS FROM APOPTOSIS TRIGGERED BY [3H]-DECAY-INDUCED DNA DAMAGE Cardiovascular Pathology. 13: 92. DOI: 10.1016/J.Carpath.2004.03.271 |
0.659 |
|
| 2004 |
Orlov SN, Thorin-Trescases N, Pchejetski D, Taurin S, Tremblay J, Hamet P. ENDOTHELIAL CELL DEATH TRIGGERED BY OUABAIN: EVIDENCE FOR NOVEL FUNCTION OF THE NA+,K+−ATPASE. Cardiovascular Pathology. 13: 54-55. DOI: 10.1016/J.Carpath.2004.03.160 |
0.622 |
|
| 2003 |
Taurin S, Hamet P, Orlov SN. [Na/K pump and intracellular monovalent cations: novel mechanism of excitation-transcription coupling involved in inhibition of apoptosis]. Molekuliarnaia Biologiia. 37: 371-81. PMID 12815944 DOI: 10.1023/A:1024266722564 |
0.635 |
|
| 2003 |
Orlov SN, Pchejetski DV, Sarkissian SD, Adarichev V, Taurin S, Pshezhetsky AV, Tremblay J, Maximov GV, deBlois D, Bennett MR, Hamet P. [3H]-thymidine labelling of DNA triggers apoptosis potentiated by E1A-adenoviral protein. Apoptosis : An International Journal On Programmed Cell Death. 8: 199-208. PMID 12766480 DOI: 10.1023/A:1022931028235 |
0.631 |
|
| 2003 |
Pchejetski D, Taurin S, Der Sarkissian S, Lopina OD, Pshezhetsky AV, Tremblay J, deBlois D, Hamet P, Orlov SN. Inhibition of Na+,K+-ATPase by ouabain triggers epithelial cell death independently of inversion of the [Na+]i/[K+]i ratio. Biochemical and Biophysical Research Communications. 301: 735-44. PMID 12565842 DOI: 10.1016/S0006-291X(02)03002-4 |
0.622 |
|
| 2003 |
Orlov SN, Pchejetski DV, Sarkissian SD, Adarichev V, Taurin S, Pshezhetsky AV, Tremblay J, Maximov GV, DeBlois D, Bennett MR, Hamet P. [3H]-thymidine labelling of DNA triggers apoptosis potentiated by E1A-adenoviral protein Apoptosis. 8: 199-208. DOI: 10.1023/A:1022931028235 |
0.594 |
|
| 2002 |
Taurin S, Seyrantepe V, Orlov SN, Tremblay TL, Thibault P, Bennett MR, Hamet P, Pshezhetsky AV. Proteome analysis and functional expression identify mortalin as an antiapoptotic gene induced by elevation of [Na+]i/[K+]i ratio in cultured vascular smooth muscle cells. Circulation Research. 91: 915-22. PMID 12433836 DOI: 10.1161/01.Res.0000043020.45534.3E |
0.649 |
|
| 2002 |
Taurin S, Dulin NO, Pchejetski D, Grygorczyk R, Tremblay J, Hamet P, Orlov SN. c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism. The Journal of Physiology. 543: 835-47. PMID 12231642 DOI: 10.1113/Jphysiol.2002.023259 |
0.592 |
|
| 2002 |
Taurin S, Ryazhsky GG, Maximova NV, Chuchalin AG, Hamet P, Pshezhetsky AV, Orlov SN. Suppression of programmed cell death by intracellular cAMP is not mediated by expression of genes encoding an inhibitor of apoptosis. Biochemistry. Biokhimii︠a︡. 67: 254-9. PMID 11952423 DOI: 10.1023/A:1014478417580 |
0.615 |
|
| 2002 |
Orlov SN, Taurin S, Hamet P. The alpha1-Na/K pump does not mediate the involvement of ouabain in the development of hypertension in rats. Blood Pressure. 11: 56-62. PMID 11926353 DOI: 10.1080/080370502753543972 |
0.592 |
|
| 2001 |
Orlov SN, Taurin S, Tremblay J, Hamet P. Inhibition of Na+,K+ pump affects nucleic acid synthesis and smooth muscle cell proliferation via elevation of the [Na+]i/[K+]i ratio: possible implication in vascular remodelling. Journal of Hypertension. 19: 1559-65. PMID 11564975 DOI: 10.1097/00004872-200109000-00007 |
0.639 |
|
| 2001 |
Thorin-Trescases N, Orlov SN, Taurin S, Dulin NO, Allen BG, deBlois D, Tremblay J, Pshezhetsky AV, Hamet P. Antiproliferative effect of brief exposure to cholera toxin in vascular smooth muscle cells: role of cAMP and protein kinase A. Canadian Journal of Physiology and Pharmacology. 79: 471-80. PMID 11430584 DOI: 10.1139/Y01-017 |
0.58 |
|
| 2000 |
Orlov SN, Taurin S, Thorin-Trescases N, Dulin NO, Tremblay J, Hamet P. Inversion of the intracellular Na(+)/K(+) ratio blocks apoptosis in vascular smooth muscle cells by induction of RNA synthesis. Hypertension. 35: 1062-8. PMID 10818065 DOI: 10.1161/01.Hyp.35.5.1062 |
0.62 |
|
| 2000 |
Orlov SN, Taurin S, Tremblay J, Hamet P. INTRACELLULAR Na+/K+ RATIO AND cAMP SIGNALLING Journal of Hypertension. 18: S76. DOI: 10.1097/00004872-200006001-00260 |
0.562 |
|
| Show low-probability matches. |